IBM Stock Climbs as Quantum Lead and AI Backlog Build Bull Case

TLDR

• Bank of America named IBM a frontrunner in quantum computing on June 29, citing its manufacturing base and qubit progress tracking.
• IBM stock rose 2.3% Tuesday to open at $277.83, with a 52-week range of $212.34 to $332.46.
• Generative AI now makes up about 30% of IBM’s consulting pipeline, with its AI book of business growing from $7.5 billion to $12.5 billion in three quarters.
• Simmons Bank increased its IBM stake by 16.7% in the first quarter, now holding 15,660 shares worth $3.8 million.
• Wall Street rates IBM a “Moderate Buy” with an average price target around $306.94, implying further upside from current levels.

---

IBM stock climbed 2.3% on Tuesday, opening at $277.83. The move comes as the company picks up praise on two fronts: quantum computing and artificial intelligence.

International Business Machines Corporation, IBM

Bank of America called IBM a frontrunner in quantum computing on June 29. The analyst pointed to IBM’s manufacturing base for its supply chain as a key strength. The firm also tracks programming qubits, qubit operations, and throughput to measure progress against rivals.

IBM’s quantum day reportedly showed the company ahead of competitors in research documentation. That builds on a separate milestone this month: IBM introduced what it calls the world’s first sub-1 nanometer chip.

IBM’s AI Strategy Is Quietly Paying Off

IBM doesn’t build flashy AI models. Instead, it helps large companies plug AI tools into their existing systems, data, and compliance setups.

That approach is starting to show up in the numbers. In Q1 2026, IBM reported $15.9 billion in revenue, up 9% year over year. Software revenue grew 11%, and recurring software revenue hit $24.6 billion.

Free cash flow came in at $2.2 billion, IBM’s strongest Q1 figure in a decade. Generative AI now makes up about 30% of the company’s total consulting pipeline.

IBM’s AI book of business grew from $7.5 billion to $12.5 billion over three quarters. Clients aren’t just asking questions anymore. They’re signing contracts.

IBM currently trades at a forward P/E of around 26.41x. That’s nearly a 20% discount to the sector median of 33.02x.

Institutional Investors Keep Adding Shares

Simmons Bank grew its IBM stake by 16.7% in the first quarter, according to a recent SEC filing. The firm bought 2,243 additional shares, bringing its total to 15,660 shares worth $3.8 million.

Other institutional investors made similar moves. Family CFO Inc, Basepoint Wealth, Portus Wealth Advisors, Joseph Group Capital Management, and Cornerstone Financial Management all opened new positions in IBM during recent quarters.

Institutional investors and hedge funds now own 58.96% of IBM’s stock. That’s a fairly high concentration for a company of this size.

IBM also continues to reward shareholders directly. The company raised its quarterly dividend to $1.69 per share, paid out on June 10th. That’s a $6.76 annualized dividend and a yield of 2.4%, marking 31 straight years of dividend increases.

IBM last reported quarterly earnings on April 22nd, posting $1.91 EPS against a consensus estimate of $1.81. Revenue of $15.92 billion also beat the $15.60 billion analysts expected.

Return on equity came in at 37.23%, with a net margin of 15.61%. Analysts predict IBM will post full-year EPS of 12.39 for 2026.

Several analysts have weighed in recently. HSBC upgraded IBM from “reduce” to “hold” in April. KeyCorp moved to “sector weight” in June, while Wolfe Research downgraded the stock to “peer perform.”

Royal Bank of Canada reaffirmed an “outperform” rating, and Wall Street Zen upgraded IBM from “sell” to “hold.” Overall, one analyst rates IBM a Strong Buy, seventeen rate it a Buy, and nine rate it a Hold.

The consensus rating sits at “Moderate Buy,” with an average price target of $306.94. That implies further upside from Tuesday’s open of $277.83.